Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study

Completed

Conditions studied: Pulmonary Disease, Chronic Obstructive

In brief

The primary objectives of the study are to use US and UK data to describe the characteristics of Chronic Obstructive Pulmonary Disease (COPD) patients according to various demographic, lifestyle, clinical, and medication use.

Key facts

Study ID

NCT04926233

Run by

Boehringer Ingelheim

People needed

1371146

Starts

2019-11-15

Expected to finish

2020-04-14

Last updated by the study team

2021-11-15

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• parent cohort
• - COPD diagnosis
• child cohort
• - any initiation of first maintenance therapy after July 1, 2015
• grandchild cohort -- any initiation of second maintenance therapy after August 2, 2015

You may not qualify if…

• parent cohort
• age <40 on index date
• any COPD diagnosis in baseline
• any use of long-acting muscarinic antagonists (LAMA), long-acting beta-agonists (LABA), or inhaled corticosteroid (ICS) in baseline
• <365 days of continuous medical and pharmacy coverage

Where it is running

• AETION inc — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.